Nov 2, 2021 Ottobock has entered into an agreement to acquire SuitX . Ottobock based at Duderstadt, Niedersachsen, Germany. “Ottobock is the leading innovator for […]
Guidemark Health acquired by Arsenal Capital Partners
Nov 2, 2021 Arsenal Capital Partners has entered into an agreement to acquire Guidemark Health . Arsenal Capital Partners based at New York, New York, […]
Series A – Nitrase Therapeutics
On Nov 2, 2021 Nitrase Therapeutics closed a Series A round and raised $7,000,000 from AbbVie Biotech Ventures, Alexandria Venture Investments, Bristol Myers Squibb, Dementia […]
Series D – Antiva Biosciences
On Nov 2, 2021 Antiva Biosciences closed a Series D round and raised $31,000,000 from Adjuvant Capital, Alexandria Venture Investments, Avestria Ventures, Brace Pharma, Canaan […]
Series B – Biolinq
On Nov 2, 2021 Biolinq closed a Series B round and raised $100,000,000 from Able Partners, Aphelion Capital, Ascensia Diabetes Care, AXA Investment Managers, Cirrus […]
Series D – Cambridge Epigenetix
On Nov 2, 2021 Cambridge Epigenetix closed a Series D round and raised $88,000,000 from Ahren Innovation Capital, GV, New Science Ventures, Sequoia Capital, Temasek […]
Venture Round – Shoreline Biosciences
On Nov 2, 2021 Shoreline Biosciences closed a Venture – Series Unknown round and raised $140,000,000 from Ally Bridge Group, BeiGene, Boxer Capital, BVF Partners, […]
Series A – Nitrase Therapeutics
On Nov 2, 2021 Nitrase Therapeutics closed a Series A round and raised $7,000,000 from AbbVie Biotech Ventures, Alexandria Venture Investments, Bristol Myers Squibb, Dementia […]
Series D – Antiva Biosciences
On Nov 2, 2021 Antiva Biosciences closed a Series D round and raised $31,000,000 from Adjuvant Capital, Alexandria Venture Investments, Avestria Ventures, Brace Pharma, Canaan […]
Series A – Aktiia
On Nov 2, 2021 Aktiia closed a Series A round and raised $17,500,000 from 415 CAPITAL, Draper Esprit, Redalpine, Translink Capital, Verve Ventures, featuring lead […]
